TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
The Jakarta Post - Logo Mobile

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Hydroxychloroquine

Malaria drug touted by Trump for coronavirus fails another test
World 5 years ago

Malaria drug touted by Trump for coronavirus fails another test

Among patients given hydroxychloroquine, 32.3% ended up needing a ventilator or dying, compared with 14.9% of patients who were not given the drug.
US vaccine expert says he was removed for opposing Trump-backed chloroquine
World 5 years ago

US vaccine expert says he was removed for opposing Trump-backed chloroquine

The head of the US agency in charge of developing a vaccine against coronavirus said Wednesday that he was removed from his job for opposing the chloroquine treatment promoted by President Donald Trump.
No benefit, higher death rate for malaria drug in coronavirus study
World 5 years ago

No benefit, higher death rate for malaria drug in coronavirus study

A malaria drug widely touted as a potential cure for COVID-19 showed no benefit against the disease over standard care -- and was in fact associated with more deaths, the biggest study of its kind showed Tuesday.
Trump-backed drug to be tested on thousands in Mumbai slums
World 5 years ago

Trump-backed drug to be tested on thousands in Mumbai slums

The city officials are identifying a target group which will receive hydroxychloroquine, according to Suresh Kakani, additional commissioner at Municipal Corporation of Greater Mumbai. Medical experts are being consulted on the duration of dosage, he said, adding that a decision was expected in a couple of days.
Novartis, US drug regulator agree to malaria drug trial against COVID-19
Health 5 years ago

Novartis, US drug regulator agree to malaria drug trial against COVID-19

Novartis has won the go-ahead from the US Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine against COVID-19 disease, the Swiss drugmaker said on Monday, to see if it helps patients.
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19
SE Asia 5 years ago

India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19

India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of COVID-19 patients.
Senegal says hydroxychloroquine virus treatment is promising
Health 5 years ago

Senegal says hydroxychloroquine virus treatment is promising

"The results we have seen reassure us and reassure my whole team, and we will continue in this direction."
Malaria drug chloroquine no better than regular coronavirus care, study finds
Health 5 years ago

Malaria drug chloroquine no better than regular coronavirus care, study finds

Hydroxychloroquine, a medicine for malaria that President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found.
The Jakarta Post - Premium Subscription Banner
The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2026 PT. Bina Media Tenggara

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.